Viracta Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIRX and other ETFs, options, and stocks.

About VIRX

Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. 

CEO
Mark A. Rothera
CEOMark A. Rothera
Employees
40
Employees40
Headquarters
Cardiff, California
HeadquartersCardiff, California
Founded
1998
Founded1998
Employees
40
Employees40

VIRX Key Statistics

Market cap
32.60M
Market cap32.60M
Price-Earnings ratio
-0.64
Price-Earnings ratio-0.64
Dividend yield
—
Dividend yield—
Average volume
172.32K
Average volume172.32K
High today
$0.864
High today$0.864
Low today
$0.8201
Low today$0.8201
Open price
$0.85
Open price$0.85
Volume
37.68K
Volume37.68K
52 Week high
$2.38
52 Week high$2.38
52 Week low
$0.43
52 Week low$0.43
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.